KAHTY yields 105.26% · JNJ yields 2.13%● Live data
📍 KAHTY pulled ahead of the other in Year 1
Combined, KAHTY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KAHTY + JNJ for your $10,000?
Kahoot! ASA operates a game-based learning platform in the United States, Canada, Europe, the Asia Pacific, the Latin America and the Caribbean, Africa, the Middle East, and India. The company's platforms help to create, share, and host learning sessions. It offers Kahoot! Learning platform for learning and engagement services; employee engagement and learning platforms, such as Actimo and Motimate; Drops, a language learning app for visuals and play; Kahoot! DragonBox app for math learning; and Kahoot! Poio Read app, which empowers children to learn to read through play. The company also provides Kahoot! Academy, a knowledge platform, online community, and marketplace, which allows educators and publishers to join and create learning communities, as well as provides parents and learners with access to learning content from the educators; Kahoot! 360 Spirit, a collaborative platform for organizations that seek to connect teams and individuals; Kahoot! EDU support program, a site license for schools and districts; and Whiteboard.fi, an online whiteboard that provides learning tools for educators, teachers, and classrooms. In addition, it offers Kahoot! Zoom App platform for engagement and learning to virtual meetings and events; and Clever, a single sign-on digital learning platform for teachers and students. The company has approximately 2 billion participating players in approximately 200 countries. Kahoot! ASA was founded in 2012 and is headquartered in Oslo, Norway.
Full KAHTY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.